Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data-Reference-Cited by-同舟云学术

Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data

Published:2021-05-16 Issue:1 Volume:100 Page:89-95
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmologica

Author:

Subhi Yousif¹²^ORCID,Bjerager Jakob¹,Boon Camiel J.F.³⁴,van Dijk Elon H.C.³^ORCID

Affiliation:

1. Department of Ophthalmology Rigshospitalet‐Glostrup Copenhagen Denmark

2. Department of Ophthalmology Zealand University Hospital Roskilde Denmark

3. Department of Ophthalmology Leiden University Medical Center Leiden the Netherlands

4. Department of Ophthalmology Amsterdam University Medical Centers University of Amsterdam the Netherlands

Funder

Stichting tot Verbetering van het Lot der Blinden

Algemene Nederlandse Vereniging ter voorkoming van Blindheid

Rotterdamse Stichting Blindenbelangen

Stichting Blindenhulp

Landelijke Stichting voor Blinden en Slechtzienden

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.14901

Reference18 articles.

1. Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life

2. Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial

3. Pachychoroid disease

4. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis

5. The Incidence of Central Serous Chorioretinopathy in Olmsted County, Minnesota, 1980–2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic accuracy of OCT angiography for macular neovascularization in central serous chorioretinopathy: A systematic review and meta‐analysis;Acta Ophthalmologica;2024-07-11

2. Perspectives and Update on the Global Shortage of Verteporfin (Visudyne®);Ophthalmology and Therapy;2024-05-16

3. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHY;Retina;2024-02

4. Topical non‐steroidal anti‐inflammatory drugs for central serous chorioretinopathy: A systematic review and meta‐analysis;Acta Ophthalmologica;2023-08-08

5. Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China;Annals of Medicine;2023-06-29